146 related articles for article (PubMed ID: 37171354)
1. Identification of immune cell infiltration profiles in renal cell carcinoma and their clinical significance.
Wang L; Song L
Medicine (Baltimore); 2023 May; 102(19):e33732. PubMed ID: 37171354
[TBL] [Abstract][Full Text] [Related]
2. Immune infiltration in renal cell carcinoma.
Zhang S; Zhang E; Long J; Hu Z; Peng J; Liu L; Tang F; Li L; Ouyang Y; Zeng Z
Cancer Sci; 2019 May; 110(5):1564-1572. PubMed ID: 30861269
[TBL] [Abstract][Full Text] [Related]
3. Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma.
Wang Q; Tang H; Luo X; Chen J; Zhang X; Li X; Li Y; Chen Y; Xu Y; Han S
Front Immunol; 2022; 13():890150. PubMed ID: 35686121
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy and Immune Infiltration in Patients with Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis.
Hou L; Liu X
Genet Res (Camb); 2023; 2023():3898610. PubMed ID: 37065178
[TBL] [Abstract][Full Text] [Related]
5. PD-L1 expression and infiltration by CD4
Lee HJ; Shin DH; Lee YJ; Lee SJ; Hwang CS; Kim A; Park WY; Lee JH; Choi KU; Kim JY; Lee CH; Sol MY; Park SW
Histopathology; 2020 Apr; 76(5):714-721. PubMed ID: 31841221
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma.
Tripathi A; Lin E; Xie W; Flaifel A; Steinharter JA; Stern Gatof EN; Bouchard G; Fleischer JH; Martinez-Chanza N; Gray C; Mantia C; Thompson L; Wei XX; Giannakis M; McGregor BA; Choueiri TK; Agarwal N; McDermott DF; Signoretti S; Harshman LC
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33177176
[TBL] [Abstract][Full Text] [Related]
8. The impact of TNFSF14 on prognosis and immune microenvironment in clear cell renal cell carcinoma.
Xu F; Guan Y; Zhang P; Xue L; Yang X; Gao K; Chong T
Genes Genomics; 2020 Sep; 42(9):1055-1066. PubMed ID: 32725578
[TBL] [Abstract][Full Text] [Related]
9. Renal Cell Carcinoma-Infiltrating CD3
Lee HW; Park C; Joung JG; Kang M; Chung YS; Oh WJ; Yeom SY; Park WY; Kim TJ; Seo SI
Curr Issues Mol Biol; 2021 May; 43(1):226-239. PubMed ID: 34071865
[TBL] [Abstract][Full Text] [Related]
10. Profiles of tumor-infiltrating immune cells in renal cell carcinoma and their clinical implications.
Zhu G; Pei L; Yin H; Lin F; Li X; Zhu X; He W; Gou X
Oncol Lett; 2019 Nov; 18(5):5235-5242. PubMed ID: 31612034
[TBL] [Abstract][Full Text] [Related]
11. FDC-SP as a diagnostic and prognostic biomarker and modulates immune infiltrates in renal cell carcinoma.
Chang F; Zhang JH; Wu WS; Tang S; Lv Z; Chen FM
BMC Bioinformatics; 2023 Mar; 24(1):91. PubMed ID: 36899339
[TBL] [Abstract][Full Text] [Related]
12. A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes.
Cao P; Wu JY; Zhang JD; Sun ZJ; Zheng X; Yu BZ; Cao HY; Zhang FL; Gao ZH; Wang W
BMC Cancer; 2022 Jun; 22(1):691. PubMed ID: 35739510
[TBL] [Abstract][Full Text] [Related]
13. Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis.
Yu B; Zhang J; Sun Z; Cao P; Zheng X; Gao Z; Cao H; Zhang F; Wang W
Medicine (Baltimore); 2021 Jan; 100(1):e24257. PubMed ID: 33429832
[TBL] [Abstract][Full Text] [Related]
14. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma.
Thompson RH; Dong H; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Kwon ED
Clin Cancer Res; 2007 Mar; 13(6):1757-61. PubMed ID: 17363529
[TBL] [Abstract][Full Text] [Related]
15. Questionable relevance of gamma delta T lymphocytes in renal cell carcinoma.
Inman BA; Frigola X; Harris KJ; Kuntz SM; Lohse CM; Leibovich BC; Kwon ED
J Immunol; 2008 Mar; 180(5):3578-84. PubMed ID: 18292585
[TBL] [Abstract][Full Text] [Related]
16. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
17. Papillary renal cell carcinoma: clinicopathological characteristics and evaluation of prognosis in 42 patients.
Onishi T; Ohishi Y; Goto H; Suzuki M; Miyazawa Y
BJU Int; 1999 Jun; 83(9):937-43. PubMed ID: 10368232
[TBL] [Abstract][Full Text] [Related]
18. Integrative bioinformatics analysis of a prognostic index and immunotherapeutic targets in renal cell carcinoma.
Tao H; Li Z; Mei Y; Li X; Lou H; Dong L; Zhou L
Int Immunopharmacol; 2020 Oct; 87():106832. PubMed ID: 32738597
[TBL] [Abstract][Full Text] [Related]
19. Identification of an immune-related risk signature for predicting prognosis in clear cell renal cell carcinoma.
Hua X; Chen J; Su Y; Liang C
Aging (Albany NY); 2020 Feb; 12(3):2302-2332. PubMed ID: 32028264
[TBL] [Abstract][Full Text] [Related]
20. Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7.
Su B; Zhao W; Shi B; Zhang Z; Yu X; Xie F; Guo Z; Zhang X; Liu J; Shen Q; Wang J; Li X; Zhang Z; Zhou L
Mol Cancer; 2014 Sep; 13():206. PubMed ID: 25193015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]